Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Respiratory Disease Testing Global Market Report 2025
Request Sample Buy Now
Global Respiratory Disease Testing Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Respiratory Disease Testing Global Market Report 2025

By Test Type (Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests), By Products (Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Products), By Application (Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis Female, Other Application), By End-User (Hospitals, Physician clinics, Clinical laboratories, Other End-User) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Respiratory Disease Testing Market Overview

• Respiratory Disease Testing market size has reached to $3.6 billion in 2024

• Expected to grow to $4.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%

• Growth Driver: Surging Prevalence Of Respiratory Diseases Sparks Growth In The Respiratory Disease Testing Market

• Market Trend: Respiratory Disease Testing Market Advances With Cutting-Edge AI Technologies

• North America was the largest region in 2024.

What Is Covered Under Respiratory Disease Testing Market?

Respiratory disease testing refers to the treatment process of testing for various respiratory diseases using physical examinations. It helps diagnose the lung condition and measures how fast it can blow air out, so the test's results can assist a clinician in diagnosing respiratory disease even before a patient experience symptom.

The main types of tests involved in respiratory disease testing are imaging tests, mechanical tests, and In-Vitro Diagnostic Tests. Imaging tests refer to a subset of diagnostic procedures that provide in-depth images of various bodily regions. The products used are lung volume, imaging, spirometry, peak flow, Blood Gas, and others. It is applied for several applications such as chronic obstructive pulmonary disease, lung cancer, asthma, female tuberculosis, and others used in hospitals, physician clinics, clinical laboratories, and others.

Respiratory Disease Testing Market Size and growth rate 2025 to 2029: Graph

What Is The Respiratory Disease Testing Market Size 2025 And Growth Rate?

The respiratory disease testing market size has grown steadily in recent years. It will grow from$3.6 billion in 2024 to $3.74 billion in 2025 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to environmental factors and pollution, tobacco smoking epidemic, occupational respiratory hazards, awareness and health education programs, government initiatives for disease control

What Is The Respiratory Disease Testing Market Growth Forecast?

The respiratory disease testing market size is expected to see strong growth in the next few years. It will grow to $4.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise in airborne respiratory viruses, focus on home-based testing solutions, increased research in precision medicine, continued environmental health concerns, focus on early intervention and prevention. Major trends in the forecast period include point-of-care testing, integration of artificial intelligence (ai), remote monitoring technologies, telehealth services, customized biomarker panels, enhanced breath analysis techniques.

The forecast of 5.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. diagnostic labs by increasing the cost of spirometry sensors and exhaled nitric oxide analyzers sourced from Italy and Israel, thereby slowing pulmonary function assessments and elevating respiratory care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Respiratory Disease Testing Market Segmented?

1) By Test Type: Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests

2) By Products: Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Products

3) By Application: Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis Female, Other Application

4) By End-User: Hospitals, Physician clinics, Clinical laboratories, Other End-User

Subsegments:

1) By Imaging Tests: X-rays, Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans

2) By Mechanical Tests: Spirometry, Peak Flow Measurement, Lung Volume Measurement, Diffusion Capacity Tests

3) By In-Vitro Diagnostic Tests: PCR Tests, Antigen Tests, Antibody Tests, Culture Tests

What Is Driving The Respiratory Disease Testing Market? Surging Prevalence Of Respiratory Diseases Sparks Growth In The Respiratory Disease Testing Market

The rising prevalence of respiratory diseases will boost the respiratory disease testing market going forward. Respiratory diseases refer to medical conditions that affect the respiratory system, which includes the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. Respiratory disease testing is primarily used for the early detection and diagnosis of respiratory conditions, which can lead to earlier treatment and management. This can help prevent the progression of the disease and is also essential for controlling the spread of infectious respiratory diseases and reducing the risk of complications. For instance, in September 2022, according to the data from the NCD Alliance, a Switzerland-based civil society organization, lung cancer was the leading cause of cancer deaths worldwide, with 2.2 million new cases and 1.8 million fatalities anticipated year on year. Further, chronic respiratory disorders impacted 550 million adults globally, and 4.2 million people died, or 7 %. Therefore, the rising prevalence of respiratory diseases will drive the respiratory disease testing industry forward

What Is Driving The Respiratory Disease Testing Market? Impact Of Tobacco Smoking On The Respiratory Disease Testing Market

The growing incidence of tobacco smoking is expected to propel the growth of the respiratory disease testing market going forward. Tobacco smoking is the practice of burning dried leaves of the tobacco plant (Nicotiana tabacum) and inhaling the resulting smoke. Respiratory disease testing plays a crucial role in the care of tobacco smokers by tracking changes in lung function over time, allowing healthcare professionals to assess the effectiveness of smoking cessation efforts and adjust treatment plans as needed. For instance, in September 2024, according to the Centers for Disease Control and Prevention, a US-based government agency Tobacco use continues to be the primary cause of preventable disease and death in the United States. In 2022, approximately 49.2 million adults, or 19.8%—nearly 1 in 5—reported using tobacco products. Therefore, the growing incidence of tobacco smoking is driving the growth of the respiratory disease testing industry.

Who Are The Major Players In The Global Respiratory Disease Testing Market?

Major companies operating in the respiratory disease testing market include Medtronic plc, Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Masimo Corporation, Hamilton Medical AG, Drägerwerk AG & Co. KGaA, Schiller AG, Nonin Medical Inc., Natus Medical Incorporated

What Are The Key Trends Of The Global Respiratory Disease Testing Market? Respiratory Disease Testing Market Advances With Cutting-Edge AI Technologies

Technological advancements are a key trend gaining popularity in the respiratory disease testing market. Major companies operating in respiratory disease testing are focused on developing artificial intelligence and machine learning technologies to optimize treatment protocols and improve patient outcomes to strengthen their position in the market. For instance, in March 2022, Respira Labs, a US-based healthcare technology company, launched an AI-powered wearable device called Sylvee for monitoring lung function. The device is designed to be worn as a chest strap and uses AI and machine learning algorithms to analyze data from multiple sensors that measure breathing rate, volume, and patterns. It can help with the early diagnosis and management of chronic obstructive pulmonary disease (COPD), asthma, and COVID-19, and the device uses advanced AI algorithms to analyze breath sounds and provide real-time feedback on lung function.

What Are The Key Trends Of The Global Respiratory Disease Testing Market? Innovative Pulmonary Function Testing In The Respiratory Disease Testing Market

Major companies operating in the respiratory disease testing market are focused on developing advanced products, such as pulmonary function testing, to gain a competitive edge in the market. Pulmonary function tests are a group of tests that measure how well the lungs are working and how well a person can breathe. For instance, in March 2023, Vitalograph Ltd., a UK-based provider of respiratory diagnostics, launched VitaloPFT. The VitaloPFT Series delivers advanced respiratory diagnostic solutions through a range of detailed pulmonary function testing options. It offers healthcare providers a cost-effective solution for advanced respiratory diagnostics, enabling them to deliver high-quality care. It features an intuitive interface and user-friendly design that simplifies the PFT process for healthcare professionals, making it easy to operate and navigate.

Need data on a specific region in this market?
Request Customisation

Respiratory Disease Testing Market Merger And Acquisition: Caire Inc. Expands Medical Technology Portfolio With Strategic Acquisition Of Mgc Diagnostics Holdings Inc.

In January 2023, CAIRE Inc., a US-based medical supply and manufacturing company, acquired MGC Diagnostics Holdings for an undisclosed amount. With this acquisition, CAIRE Inc. wants to increase the scope of its product line, diversify its income sources by adding cardiorespiratory diagnostic products to its portfolio, and strengthen its position as a market leader in medical technology for respiratory and cardiorespiratory diagnostics. MGC Diagnostics Holdings Inc. is a US-based medical technology company that provides cardiorespiratory diagnostic solutions and respiratory disease testing products.

Regional Analysis For The Global Respiratory Disease Testing Market

North America was the largest region in the respiratory disease testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the global respiratory disease testing market during the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Respiratory Disease Testing Market?

The respiratory disease testing market includes revenues earned by entities by providing services such as exhaled nitric oxide tests lung function tests. oxygen therapy, bronchoscopy, ultrasonography, nuclear lung scanning, and pulmonary artery angiography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Respiratory Disease Testing Industry?

The respiratory disease testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory disease testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Respiratory Disease Testing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $3.74 billion
Revenue Forecast In 2034 $4.64 billion
Growth Rate CAGR of 5.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Test Type: Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests
2) By Products: Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Products
3) By Application: Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis Female, Other Application
4) By End-User: Hospitals, Physician clinics, Clinical laboratories, Other End-User Subsegments: 1) By Imaging Tests: X-rays, Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans
2) By Mechanical Tests: Spirometry, Peak Flow Measurement, Lung Volume Measurement, Diffusion Capacity Tests
3) By In-Vitro Diagnostic Tests: PCR Tests, Antigen Tests, Antibody Tests, Culture Tests
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Medtronic plc, Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Masimo Corporation, Hamilton Medical AG, Drägerwerk AG & Co. KGaA, Schiller AG, Nonin Medical Inc., Natus Medical Incorporated
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Respiratory Disease Testing Market Characteristics

3. Respiratory Disease Testing Market Trends And Strategies

4. Respiratory Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Respiratory Disease Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Respiratory Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Respiratory Disease Testing Market Growth Rate Analysis

5.4. Global Respiratory Disease Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Respiratory Disease Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Respiratory Disease Testing Total Addressable Market (TAM)

6. Respiratory Disease Testing Market Segmentation

6.1. Global Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Imaging Tests

Mechanical Tests

In-Vitro Diagnostic Tests

6.2. Global Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lung Volume

Imaging

Spirometry

Peak Flow

Blood Gas

Other Products

6.3. Global Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chronic Obstructive Pulmonary Disease

Lung Cancer

Asthma

Tuberculosis Female

Other Application

6.4. Global Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Physician clinics

Clinical laboratories

Other End-User

6.5. Global Respiratory Disease Testing Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

X-rays

Computed Tomography (CT) Scans

Magnetic Resonance Imaging (MRI)

Positron Emission Tomography (PET) Scans

6.6. Global Respiratory Disease Testing Market, Sub-Segmentation Of Mechanical Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Spirometry

Peak Flow Measurement

Lung Volume Measurement

Diffusion Capacity Tests

6.7. Global Respiratory Disease Testing Market, Sub-Segmentation Of In-Vitro Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

PCR Tests

Antigen Tests

Antibody Tests

Culture Tests

7. Respiratory Disease Testing Market Regional And Country Analysis

7.1. Global Respiratory Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Respiratory Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Disease Testing Market

8.1. Asia-Pacific Respiratory Disease Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Disease Testing Market

9.1. China Respiratory Disease Testing Market Overview

9.2. China Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Disease Testing Market

10.1. India Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Disease Testing Market

11.1. Japan Respiratory Disease Testing Market Overview

11.2. Japan Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Disease Testing Market

12.1. Australia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Disease Testing Market

13.1. Indonesia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Disease Testing Market

14.1. South Korea Respiratory Disease Testing Market Overview

14.2. South Korea Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Disease Testing Market

15.1. Western Europe Respiratory Disease Testing Market Overview

15.2. Western Europe Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Disease Testing Market

16.1. UK Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Disease Testing Market

17.1. Germany Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Disease Testing Market

18.1. France Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Disease Testing Market

19.1. Italy Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Disease Testing Market

20.1. Spain Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Disease Testing Market

21.1. Eastern Europe Respiratory Disease Testing Market Overview

21.2. Eastern Europe Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Disease Testing Market

22.1. Russia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Disease Testing Market

23.1. North America Respiratory Disease Testing Market Overview

23.2. North America Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Disease Testing Market

24.1. USA Respiratory Disease Testing Market Overview

24.2. USA Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Disease Testing Market

25.1. Canada Respiratory Disease Testing Market Overview

25.2. Canada Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Disease Testing Market

26.1. South America Respiratory Disease Testing Market Overview

26.2. South America Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Disease Testing Market

27.1. Brazil Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Disease Testing Market

28.1. Middle East Respiratory Disease Testing Market Overview

28.2. Middle East Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Disease Testing Market

29.1. Africa Respiratory Disease Testing Market Overview

29.2. Africa Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Disease Testing Market Competitive Landscape And Company Profiles

30.1. Respiratory Disease Testing Market Competitive Landscape

30.2. Respiratory Disease Testing Market Company Profiles

30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. ResMed Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Disease Testing Market Other Major And Innovative Companies

31.1. Thermo Fisher Scientific Inc.

31.2. Becton Dickinson and Company

31.3. F. Hoffmann-La Roche Ltd.

31.4. Nihon Kohden Corporation

31.5. GE HealthCare Technologies Inc.

31.6. Fisher & Paykel Healthcare Corporation Limited

31.7. Qiagen N.V.

31.8. Medical Graphics Corporation

31.9. COSMED srl

31.10. ndd Medizintechnik AG

31.11. Vitalograph Ltd.

31.12. MGC Diagnostics Corporation

31.13. Vyaire Medical Inc.

31.14. Masimo Corporation

31.15. Hamilton Medical AG

32. Global Respiratory Disease Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Disease Testing Market

34. Recent Developments In The Respiratory Disease Testing Market

35. Respiratory Disease Testing Market High Potential Countries, Segments and Strategies

35.1 Respiratory Disease Testing Market In 2029 - Countries Offering Most New Opportunities

35.2 Respiratory Disease Testing Market In 2029 - Segments Offering Most New Opportunities

35.3 Respiratory Disease Testing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Respiratory Disease Testing Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Respiratory Disease Testing Market, Sub-Segmentation Of Mechanical Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Respiratory Disease Testing Market, Sub-Segmentation Of In-Vitro Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Respiratory Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Respiratory Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Medtronic plc Financial Performance
  • Table 79: Abbott Laboratories Financial Performance
  • Table 80: Siemens Healthineers AG Financial Performance
  • Table 81: Koninklijke Philips N.V. Financial Performance
  • Table 82: ResMed Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Respiratory Disease Testing Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Respiratory Disease Testing Market, Sub-Segmentation Of Mechanical Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Respiratory Disease Testing Market, Sub-Segmentation Of In-Vitro Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Respiratory Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Respiratory Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Medtronic plc Financial Performance
  • Figure 79: Abbott Laboratories Financial Performance
  • Figure 80: Siemens Healthineers AG Financial Performance
  • Figure 81: Koninklijke Philips N.V. Financial Performance
  • Figure 82: ResMed Inc. Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Read More About Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Respiratory Diseases Drugs Global Market Report 2022 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Adm...

View Report

Tissue Paper Converting Machine Global Market Report 2025 – By System Type (Toilet Roll Converting Lines, Kitchen Rolls Converting Lines, Folded Tissue Converting Line, Paper Napkin Converting Lines, Standalone), By Comp...

View Report

Halal Cosmetics Global Market Report 2025 – By Type (Skin Care, Hair Care, Makeup, Others), By Distribution Channel (Offline, Online), By End User (Men, Women, Unisex) – Impact of Tariff and Trade War on Market Size, Gro...

View Report

Respiratory Monitoring Devices Global Market Report 2025 – By Type (Capnographs, Gas Analyzers, Pulse Oximeters, Peak Flow Meters, Spirometers, Polysomnographs, Others Types), By Application (Chronic Obstructive Pulmonar...

View Report

Respiratory Devices And Equipment (Diagnostic) Global Market Report 2025 – By Product (Instruments And Devices, Assays And Reagents), By Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular...

View Report

Respiratory Devices And Equipment (Therapeutic And Diagnostic) Global Market Report 2025 – By Type (Diagnostic devices, Therapeutic devices, Monitoring devices), By Therapeutic Devices (Humidifiers, Nebulizers, Oxygen co...

View Report

Respiratory Monitoring Devices Global Market Report 2025 – By Type (Capnographs, Gas Analyzers, Pulse Oximeters, Peak Flow Meters, Spirometers, Polysomnographs, Others Types), By Application (Chronic Obstructive Pulmonar...

View Report

Aircraft Sensors Global Market Report 2025 – By Sensor Type (Temperature, Pressure, Position, Flow, Torque, Radar, Accelerometer, Proximity), By Aircraft Type (Narrow-Body Aircraft, Wide-Body Aircraft, Very Large Aircraf...

View Report

Frequently Asked Questions

Respiratory disease testing refers to the treatment process of testing for various respiratory diseases using physical examinations. It helps diagnose the lung condition and measures how fast it can blow air out, so the test's results can assist a clinician in diagnosing respiratory disease even before a patient experience symptom. For further insights on this market, request a sample here

The market major growth driver - Surging Prevalence Of Respiratory Diseases Sparks Growth In The Respiratory Disease Testing Market. For further insights on this market, request a sample here

The respiratory disease testing market size has grown steadily in recent years. It will grow from $3.6 billion in 2024 to $3.74 billion in 2025 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to environmental factors and pollution, tobacco smoking epidemic, occupational respiratory hazards, awareness and health education programs, government initiatives for disease control. The respiratory disease testing market size is expected to see strong growth in the next few years. It will grow to " $4.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise in airborne respiratory viruses, focus on home-based testing solutions, increased research in precision medicine, continued environmental health concerns, focus on early intervention and prevention. Major trends in the forecast period include point-of-care testing, integration of artificial intelligence (AI), remote monitoring technologies, telehealth services, customized biomarker panels, enhanced breath analysis techniques. For further insights on this market, request a sample here

The respiratory disease testingmarket covered in this report is segmented –
1) By Test Type: Imaging Tests; Mechanical Tests; In-Vitro Diagnostic Tests
2) By Products: Lung Volume; Imaging; Spirometry; Peak Flow; Blood Gas; Other Products
3) By Application: Chronic Obstructive Pulmonary Disease; Lung Cancer; Asthma; Tuberculosis Female; Other Application
4) By End-User: Hospitals; Physician clinics; Clinical laboratories; Other End-User Subsegments:
1) By Imaging Tests: X-rays; Computed Tomography (CT) Scans; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scans
2) By Mechanical Tests: Spirometry; Peak Flow Measurement; Lung Volume Measurement; Diffusion Capacity Tests
3) By In-Vitro Diagnostic Tests: PCR Tests; Antigen Tests; Antibody Tests; Culture Tests For further insights on this market, request a sample here

North America was the largest region in the respiratory disease testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the global respiratory disease testing market during the forecast period. The regions covered in the respiratory disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the respiratory disease testing market include Medtronic plc, Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Masimo Corporation, Hamilton Medical AG, Drägerwerk AG & Co. KGaA, Schiller AG, Nonin Medical Inc., Natus Medical Incorporated . For further insights on this market, request a sample here.

Major trends in this market include Respiratory Disease Testing Market Advances With Cutting-Edge AI Technologies. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Respiratory Disease Testing Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon